Action of solamargine on TNFs and cisplatin-resistant human lung cancer cells
- 1 September 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 322 (3) , 751-758
- https://doi.org/10.1016/j.bbrc.2004.07.183
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- TNF receptor subtype signalling: Differences and cellular consequencesCellular Signalling, 2002
- Chemotherapy for advanced non-small cell lung cancerLung Cancer, 2001
- New agents within the preoperative chemotherapy of non-small cell lung cancer.Lung Cancer, 2001
- Simultaneous inhibition of Rac1 and IKK pathways sensitizes lung cancer cells to TNFα-mediated apoptosisCancer Gene Therapy, 2001
- Upregulation of bcl‐2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell linesInternational Journal of Cancer, 2001
- Type II tumour necrosis factor-α receptor (TNFR2) activates c-Jun N-terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38 MAPK pathwaysBiochemical Journal, 2001
- Molecular Steps of Tumor Necrosis Factor Receptor-Mediated ApoptosisCurrent Molecular Medicine, 2001
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Expression of tumor necrosis factor receptors in human lung cancer cells and normal lung tissues.American Journal of Respiratory Cell and Molecular Biology, 1995